561 related articles for article (PubMed ID: 10379741)
1. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
2. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
5. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
Pich A; Margaria E; Chiusa L; Bortolin P; Palestro G
Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702
[TBL] [Abstract][Full Text] [Related]
6. Re: Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Metze K; Cia EM; Trevisan M
J Urol; 2000 May; 163(5):1524-5. PubMed ID: 10751879
[No Abstract] [Full Text] [Related]
7. AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.
Tomobe M; Shimazui T; Uchida K; Akaza H
Anal Cell Pathol; 2001; 22(4):193-9. PubMed ID: 11564895
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer.
Asakura T; Takano Y; Iki M; Suwa Y; Noguchi S; Kubota Y; Masuda M
J Urol; 1997 Aug; 158(2):385-8. PubMed ID: 9224308
[TBL] [Abstract][Full Text] [Related]
9. [Argentophilic nucleolar organizers and prognosis for patients with surface and locally advanced transitional cell cancer of the urinary bladder].
Korneev IA
Urologiia; 2005; (1):5-9. PubMed ID: 15776823
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
[TBL] [Abstract][Full Text] [Related]
11. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
12. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
13. [Nucleolar organizers in superficial bladder tumors. Prognostic analysis of 37 observations].
Clement T; Visseaux-Coletto B; Adnet JJ; Ploton D; Lardennois B
Prog Urol; 1991 Apr; 1(2):216-29. PubMed ID: 1844824
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
16. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
Korneyev IA; Mamaev NN; Kozlov VV; Rybakova MG; al-Shukri SH
Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
[TBL] [Abstract][Full Text] [Related]
17. Argyrophilic nucleolar organizer regions (AgNOR) of resected intrahepatic cholangiocellular carcinomas.
Hayashi H; Maeda T; Adachi E; Shimada M; Matsumata T; Takenaka K
Hepatogastroenterology; 1995; 42(5):440-4. PubMed ID: 8751192
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of double staining of MIB-1 and AgNORs in primary breast carcinoma.
Kidogawa H; Nanashima A; Yano H; Matsumoto M; Yasutake T; Nagayasu T
Anticancer Res; 2005; 25(6B):3957-62. PubMed ID: 16309183
[TBL] [Abstract][Full Text] [Related]
19. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
20. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder.
Mansour P; Crocker J; Newman J
Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
